Request Deal Involvement

EQT and ADIA completed the acquisition of Dechra Pharmaceuticals for £4.88bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

DLA Piper

legal advisors

DLA Piper

TooleyStreet

pr advisors

TooleyStreet

Investec

financial advisors

Investec

Jefferies & Company

financial advisors

Jefferies & Company

Ashurst

legal advisors to financial advisors

Ashurst

Morgan Stanley

financial advisors

Morgan Stanley

Kirkland & Ellis

legal advisors

Kirkland & Ellis

FGS Global

pr advisors

FGS Global

Bank of America

financial advisors

Bank of America

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

or

Principals

DECHRA PHARMACEUTICALS PLC

target

DECHRA PHARMACEUTICALS PLC

EQT PARTNERS AB

bidder

EQT PARTNERS AB

ABU DHABI INVESTMENT AUTHORITY (ADIA)

bidder

ABU DHABI INVESTMENT AUTHORITY (ADIA)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - EQT and ADIA completed the acquisition of Dechra Pharmaceuticals for £4.88bn.